Table 1.
Demographic and Clinical Characteristicsa
| Demographics/Clinical Characteristics | Baseline Period (n = 166) | Intervention Period (n = 84) | Total Cohort (n = 250) | P Value |
|---|---|---|---|---|
| Age, mean (standard deviation) | 53 (15) | 50 (19) | 52 (17) | .16 |
| Male | 91 (55) | 50 (59) | 141 (56) | .5 |
| Comorbid conditions | ||||
| Current smoking | 85 (51) | 42 (50) | 127 (51) | .9 |
| Alcohol abuse | 41 (25) | 22 (27) | 63 (26) | .8 |
| Diabetes mellitus | 31 (19) | 12 (16) | 43 (18) | .4 |
| COPD | 30 (18) | 27 (32) | 55 (22) | .01 |
| Asthma | 26 (16) | 7 (8) | 33 (13) | .1 |
| Cardiovascular disease | 20 (12) | 7 (8) | 27 (11) | .4 |
| HIV infection | 11 (7) | 11 (13) | 22 (9) | .09 |
| CURB-65 score | .7 | |||
| 0 | 55 (33) | 30 (35) | 85 (34) | |
| 1 | 67 (40) | 32 (32) | 99 (40) | |
| 2 | 32 (19) | 13 (16) | 45 (18) | |
| 3 | 11 (7) | 9 (11) | 20 (8) | |
| 4 | 1 (1) | 0 | 1 (0.4) | |
| Septic shock | 2 (1) | 2 (2) | 4 (2) | .5 |
| Multilobar infiltrate | 68 (41) | 32 (38) | 100 (40) | .7 |
| Bacteremia | 9 (5) | 3 (4) | 12 (5) | .5 |
Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.
a Data presented as n (%) unless otherwise noted.